Astrana Health, Inc. (NASDAQ:ASTH) Short Interest Update

Astrana Health, Inc. (NASDAQ:ASTH - Get Free Report) was the target of a large increase in short interest during the month of November. As of November 30th, there was short interest totalling 1,640,000 shares, an increase of 5.1% from the November 15th total of 1,560,000 shares. Currently, 4.6% of the shares of the company are sold short. Based on an average daily trading volume, of 299,300 shares, the short-interest ratio is currently 5.5 days.

Institutional Trading of Astrana Health

Institutional investors and hedge funds have recently made changes to their positions in the company. State Street Corp acquired a new position in Astrana Health during the third quarter worth about $91,966,000. Geode Capital Management LLC bought a new stake in shares of Astrana Health during the 3rd quarter valued at approximately $58,995,000. FMR LLC acquired a new position in Astrana Health during the 3rd quarter worth approximately $48,413,000. SteelPeak Wealth LLC bought a new position in Astrana Health in the 3rd quarter valued at approximately $39,398,000. Finally, Loomis Sayles & Co. L P acquired a new stake in Astrana Health in the third quarter valued at approximately $30,251,000. Institutional investors own 52.77% of the company's stock.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on ASTH shares. KeyCorp began coverage on Astrana Health in a report on Friday, October 11th. They set a "sector weight" rating for the company. Robert W. Baird boosted their price target on Astrana Health from $67.00 to $86.00 and gave the company an "outperform" rating in a research note on Wednesday, November 13th. TD Cowen initiated coverage on Astrana Health in a research report on Monday, October 14th. They set a "buy" rating and a $66.00 price objective on the stock. Finally, BTIG Research boosted their target price on shares of Astrana Health from $60.00 to $70.00 and gave the company a "buy" rating in a research report on Thursday, October 3rd. One equities research analyst has rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Buy" and an average target price of $65.17.

Astrana Health Price Performance

NASDAQ ASTH traded down $0.84 during midday trading on Monday, hitting $36.80. The company had a trading volume of 299,380 shares, compared to its average volume of 212,923. The firm has a 50-day moving average price of $49.04 and a 200-day moving average price of $48.12. The company has a market capitalization of $2.07 billion, a PE ratio of 28.30, a P/E/G ratio of 1.80 and a beta of 1.13. The company has a current ratio of 1.91, a quick ratio of 1.91 and a debt-to-equity ratio of 0.60. Astrana Health has a twelve month low of $34.11 and a twelve month high of $63.20.

Astrana Health (NASDAQ:ASTH - Get Free Report) last posted its quarterly earnings results on Thursday, November 7th. The company reported $0.33 EPS for the quarter, meeting analysts' consensus estimates of $0.33. The business had revenue of $478.71 million during the quarter, compared to the consensus estimate of $462.01 million. Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. During the same quarter in the previous year, the firm earned $0.47 earnings per share. As a group, analysts anticipate that Astrana Health will post 1.16 earnings per share for the current fiscal year.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.